Literature DB >> 23972904

Oral and sublingual immunotherapy for food allergy: current progress and future directions.

Timothy P Moran1, Brian P Vickery, A Wesley Burks.   

Abstract

Food allergies are increasing in prevalence and present an emerging epidemic for westernized countries. Strict dietary avoidance is the only approved management for food allergy, but accidental exposures regularly occur, leading to significant patient anxiety and decreased quality of life. Over the past decade, oral and sublingual immunotherapies have emerged as potential treatments for food allergy. While several small clinical trials have demonstrated that immunotherapy can desensitize food-allergic individuals, strategies for further enhancing safety and definitively establishing long-term efficacy are needed. This review presents an overview of recent oral and sublingual immunotherapy trials, and provides a glimpse into what the next generation of food immunotherapy may entail.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23972904      PMCID: PMC3935613          DOI: 10.1016/j.coi.2013.07.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  48 in total

1.  Possible eosinophilic esophagitis induced by milk oral immunotherapy.

Authors:  Silvia Sánchez-García; Pablo Rodríguez Del Río; Carmelo Escudero; M Jose Martínez-Gómez; M Dolores Ibáñez
Journal:  J Allergy Clin Immunol       Date:  2012-01-10       Impact factor: 10.793

2.  The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

Authors:  Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2011-11-30       Impact factor: 10.793

3.  Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.

Authors:  Edwin H Kim; J Andrew Bird; Michael Kulis; Susan Laubach; Laurent Pons; Wayne Shreffler; Pamela Steele; Janet Kamilaris; Brian Vickery; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

4.  A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Authors:  Hugh A Sampson; Donald Y M Leung; A Wesley Burks; Gideon Lack; Sami L Bahna; Stacie M Jones; Dennis A Wong
Journal:  J Allergy Clin Immunol       Date:  2011-03-11       Impact factor: 10.793

5.  Dietary baked milk accelerates the resolution of cow's milk allergy in children.

Authors:  Jennifer S Kim; Anna Nowak-Węgrzyn; Scott H Sicherer; Sally Noone; Erin L Moshier; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-05-23       Impact factor: 10.793

6.  Inadvertent exposures in children with peanut allergy.

Authors:  Nha Uyen Nguyen-Luu; Moshe Ben-Shoshan; Reza Alizadehfar; Lawrence Joseph; Laurie Harada; Mary Allen; Yvan St-Pierre; Ann Clarke
Journal:  Pediatr Allergy Immunol       Date:  2011-12-04       Impact factor: 6.377

7.  A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.

Authors:  Pooja Varshney; Stacie M Jones; Amy M Scurlock; Tamara T Perry; Alex Kemper; Pamela Steele; Anne Hiegel; Janet Kamilaris; Suzanne Carlisle; Xiaohong Yue; Mike Kulis; Laurent Pons; Brian Vickery; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

8.  Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study.

Authors:  Sangita P Patil; Julie Wang; Ying Song; Sally Noone; Nan Yang; Sylvan Wallenstein; Hugh A Sampson; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2011-07-26       Impact factor: 10.793

9.  Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy.

Authors:  Kari C Nadeau; Lynda C Schneider; Lisa Hoyte; Irene Borras; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

Review 10.  Nanoparticulate adjuvants and delivery systems for allergen immunotherapy.

Authors:  Juliana De Souza Rebouças; Irene Esparza; Marta Ferrer; María Luisa Sanz; Juan Manuel Irache; Carlos Gamazo
Journal:  J Biomed Biotechnol       Date:  2012-02-26
View more
  10 in total

1.  Future Therapies for IgE-Mediated Food Allergy.

Authors:  M Cecilia Berin
Journal:  Curr Pediatr Rep       Date:  2014-06-01

Review 2.  Is clinical tolerance possible after allergen immunotherapy?

Authors:  Timothy P Moran; A Wesley Burks
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

3.  Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.

Authors:  Magali Noval Rivas; Oliver T Burton; Petra Wise; Louis-Marie Charbonnier; Peter Georgiev; Hans C Oettgen; Rima Rachid; Talal A Chatila
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

4.  Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy.

Authors:  C M Burk; M Kulis; N Leung; E H Kim; A W Burks; B P Vickery
Journal:  Clin Exp Allergy       Date:  2016-02       Impact factor: 5.018

Review 5.  Immune mechanisms of sublingual immunotherapy.

Authors:  David C Jay; Kari C Nadeau
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

6.  Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.

Authors:  J A Wisniewski; S P Commins; R Agrawal; K E Hulse; M D Yu; J Cronin; P W Heymann; A Pomes; T A Platts-Mills; L Workman; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2015-07       Impact factor: 5.018

7.  Orally-Induced Intestinal CD4+ CD25+ FoxP3+ Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions.

Authors:  Paola Lorena Smaldini; María Lucía Orsini Delgado; Carlos Alberto Fossati; Guillermo Horacio Docena
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

8.  Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study.

Authors:  E Maina; M Pelst; M Hesta; E Cox
Journal:  BMC Vet Res       Date:  2017-01-18       Impact factor: 2.741

9.  Randomised controlled trial of a baked egg intervention in young children allergic to raw egg but not baked egg.

Authors:  Merryn Netting; Michael Gold; Patrick Quinn; Adaweyah El-Merhibi; Irmeli Penttila; Maria Makrides
Journal:  World Allergy Organ J       Date:  2017-06-16       Impact factor: 4.084

Review 10.  Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.

Authors:  Azza Abdel-Gadir; Amir H Massoud; Talal A Chatila
Journal:  F1000Res       Date:  2018-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.